| Document |
Document Title |
|
JPH10101567A |
To obtain the subject composition enabling estrogen therapy and the supplement of estrogen to mammals, in which the increase of prolactin level accompanying estrogen administration is unwanted, by compounding dehydroestorone, etc., havin...
|
|
JPH09511902A |
The invention relates to new compounds, WF15604 substances or salts thereof, having antifungal activity and inhibitory activity on cholesterol biosynthesis, to a process for the preparation thereof and to a pharmaceutical composition com...
|
|
JP2662530B2 |
An additive for cholesterol-containing food, containing a rice bran component and/or a derivative thereof as an active ingredient, a method of using same, and food treated thereby; and a process for producing mayonnaise controlled in the...
|
|
JP2617706B2 |
New steroid compounds of the general formula: (A) wherein X is a hydroxyl group and Y is a hydrogen atom, or X and Y, taken together, form an oxo group; each of the two R' radicals is independently a hydrogen atom, acyl group, a silyl gr...
|
|
JP2588267B2 |
New 19,11 beta -bridged steroids of the general formula I (I) where R1 stands for a methyl or ethyl radical, R2 for a hydrogen or chlorine atom or a C1-C4-alkyl radical, B and G, which are the same or different, respectively for a hydrog...
|
|
JPH0931094A |
To obtain the subject terpene compound known as a component of SHOMA (Cimicifugae Rhizoma), exhibiting antibacterial action, action on circulatory system, sedative action, antiinflammatory action, antipyretic action, etc., and useful as ...
|
|
JP2566574B2 |
A compound of the formula: useful as cancer preventive agent, anti-obesity agent, anti-hyperglycemic agent, anti-aging agent and anti-hypercholesterolemic agent and useful in combatting coronary diseases and autoimmune diseases. Encompas...
|
|
JP2560014B2 |
|
|
JP2557429B2 |
|
|
JP2548707B2 |
|
|
JP2512439B2 |
This invention relates to novel compounds of the formula: X and Z are independently hydrogen, halogen, lower alkyl or hydroxy, or X and Z taken together are hydroxy-imino with the proviso that when Y is methyl and Z is hydrogen, X is oth...
|
|
JPH0873490A |
PURPOSE: To obtain the subject new compound which is a specific strogin compound available by separation and purification from a plant belonging to the family Acanthaceae and having taste modifying activities and excellent in stability d...
|
|
JPH0873425A |
PURPOSE: To provide a new fluorinated vitamin D derivative free from side action when used as a remedy for osteoporosis and expected to have an improved bone-quantity improving action compared with conventional active vitamin D derivativ...
|
|
JPH0859472A |
PURPOSE: To obtain the composition containing a triterpenoid compound or its salt and a carrier for external agents, excellent in the antiphlogistic action, excellent in supply stability and productivity, and useful as an antiphlogistic ...
|
|
JPH0859482A |
PURPOSE: To provide an alcohol absorption suppressing agent containing beet saponin as an active component, effective for suppressing the alcohol concentration in blood to suppress the development of uncomfortable symptom such as drunken...
|
|
JPH07116217B2 |
|
|
JPH0791312B2 |
1. The products of general formula I : see diagramm : EP0237397,P31,F2 in which R represents : - either a hydrogen atom, - or an alkyl, alkenyl or alkynyl radical having at most 8 carbon atoms possibly substituted by a radical chosen fro...
|
|
JPH07233191A |
PURPOSE: To obtain a new saponin having an improving effect on blood flow and capable of preparing a dermal agent for external use, a bath agent, a beverage, etc., effective for, e.g. preventing and improving obstruction of the blood cir...
|
|
JPH07188032A |
PURPOSE: To prepare the subject treating medicine containing glycyrrhizin (salt) as an active ingredient, effective for the therapy of influenza infection, and reduced in side effects. CONSTITUTION: This treating medicine contains glycyr...
|
|
JPH07506582A |
Competitive progesterone antagonists, including two novel steroids, viz., 11beta,19-[4-(cyanophenyl)-o-phenylene]-17beta-hydroxy-17alp
ha-(3-hydroxyprop-1(Z)-enyl)-4-androsten-3-one and 11beta,19-[4-(3-pyridinyl)-o-phenylene]-17beta-hydr...
|
|
JPH0745512B2 |
|
|
JPH0739433B2 |
|
|
JPH07502759A |
This invention refers to the use of compounds of formula (I), wherein R is hydrogen or C1-C4 alkyl; and A is a (a), (b) or (c) group, in which R' is an acyl group; in the manufacture of a medicament for use as an aromatase inhibitor; and...
|
|
JPH0717673B2 |
The invention relates to 17-(isocyano-sulfonylmethylene)-steroids and a process for the preparation of these compounds from 17-oxo-steroids. Furthermore the invention relates to 17-formamido-sulfonylmethylene)-steroids, which compounds a...
|
|
JPH07501792A |
The present invention relates to 11 beta -substituted 14,17-ethanoestratrienes of the general formula I in which R<1> is a hydrogen atom, a C1-C12-alkanoyl, a benzoyl, a straight-chain or branched C1-C12-alkyl, a C3-C7-cycloalkyl or a C4...
|
|
JPH072893A |
PURPOSE: To obtain a new triterpen derivative which has liver protection effect and useful for treatment of viral hepatitis, alcoholic hepatitis or the like. CONSTITUTION: The derivative of the formula, is obtained by drying the seed of ...
|
|
JPH06345650A |
PURPOSE: To produce the subject preventing and treating agent effective for suppressing bone resorption action, having excellent safety and useful for the treatment of malignant hypercalcemia, Paget's disease of bone, osteoporosis, etc.,...
|
|
JPH0699470B2 |
The invention relates to a new process for the preparation of 21-hydroxy-20-keto-steroids from 17-(isocyano-sulfonylmethylene)-steroids whereby simultaneously an unsaturated bond is introduced between C16 and C17. Furthermore the inventi...
|
|
JPH0662664B2 |
The invention provides new derivatives of vitamin D3 and specifically (22E,24R)-1,24-dihydroxy- DELTA 22-vitamin D3 and (22E,24S)-1,24-dihdroxy- DELTA 22-vitamin D3. The compounds exhibit vitamin D-like activity in their ability to stimu...
|
|
JPH0660195B2 |
The present disclosure is directed to a process and intermediates for the synthesis of Vitamin D3 metabolites such as 1,25-dihydroxycholecalciferol, 25-hydroxycholecalciferol and 24R,25-dihydroxycholecalciferol from 17-keto steroids via ...
|
|
JPH06506678A |
14 alpha ,16 alpha -ethano- and 14 alpha ,16 alpha -etheno-oestratrienes of the general formula I in which A-B is a C-C single or C-C double bond, R1 is a hydrogen atom, a methyl or acyl group with 1 - 12 carbon atoms and X is oxygen or ...
|
|
JPH06506679A |
14 alpha ,17 alpha -(Propano- and 17<2>-propeno)oestratrienes of the general formula I in which R<1> is a hydrogen atom, a methyl or an acyl group with 1-12 carbon atoms, R<2> is a hydrogen atom or an acyl group with 1-12 carbon atoms an...
|
|
JPH0649717B2 |
The intermediate products of formula (II): R' = especially H or optionally substituted alkyl, alkenyl, alkynyl, aryl or aralkyl, hydroxyl, tetrahydropyranyl, tert-butoxy, optionally esterified carboxyl, amino, mono- or dialkylamino, trit...
|
|
JPH06504780A |
PCT No. PCT/EP92/00160 Sec. 371 Date Nov. 15, 1993 Sec. 102(e) Date Nov. 15, 1993 PCT Filed Jan. 24, 1992 PCT Pub. No. WO92/12990 PCT Pub. Date Aug. 6, 1992.14,16 beta -Ethano-15 beta ,161-cyclo-14 beta -estra-1,3,5(10)-trienes of genera...
|
|
JPH0635476B2 |
Oestrane and androstane derivatives of the general formula I in which X is a bromine atom, an iodine atom, a triphenyltin group or a trialkyltin group with 1 to 6 carbon atoms per alkyl radical, Y is two hydrogen atoms or one methylene g...
|
|
JPH0610187B2 |
This invention relates to hydroxylated derivatives of vitamin D2, to processes for preparing such compounds, to intermediates utilized in such processes and to certain isotopically labelled vitamin D2 compounds. The vitamin D2 derivative...
|
|
JPH0576940B2 |
The invention provides new derivatives of vitamin D3 and specifically (22E,24R)-1,24-dihydroxy- DELTA 22-vitamin D3 and (22E,24S)-1,24-dihdroxy- DELTA 22-vitamin D3. The compounds exhibit vitamin D-like activity in their ability to stimu...
|
|
JPH05239088A |
PURPOSE: To obtain the subject new compound useful as an ameliorant of cerebral function for treating motor dysfunction, intelligent dysfunction, etc., caused by cerebral hemorrhage, cerebral infarction, subarachnoidal hemorrhage, transi...
|
|
JPH0564640B2 |
1 alpha ,2 alpha -methylene-6-methylene- and 6 alpha -methylpregnenes of Formula I (I) wherein A is and R is a hydrogen atom, an acyl group, or an alkoxymethyl group are strong antiandrogens, and suitable for the topical treatment of seb...
|
|
JPH0564638B2 |
6,6-ethylene-15,16-methylene-3-oxo-17 alpha -pregn-4-ene-21,17 alpha -carbolactones of general Formula I (I) wherein is a CC-single of CC-double bond, R1 is a hydrogen atom or a methyl group, R2 is a methyl or ethyl group, and exhibit st...
|
|
JPH0564639B2 |
1. Claims for Contracting States BE, CH, LI, DE, FR, GB, IT, LU, NL, SE 17-substituted estradienes of general formula I see diagramm : EP0156284,P17,F3 wherein see diagramm : EP0156284,P17,F4 is see diagramm : EP0156284,P17,F5 or see dia...
|
|
JPH0559918B2 |
11 beta -Arylestradienes of general Formula I are disclosed (I) wherein R2 is a hydrogen atom, a methyl group, or an ethyl group, R3 is a hydrogen atom or an acyl group, R1 and A-B have various meanings, which possess antigestagen and an...
|
|
JPH0541603B2 |
|
|
JPH0533713B2 |
|
|
JPH0565293A |
PURPOSE: To provide a new compd. which has positive contractive inotropic activity and vasodilation activity and is useful for treatments for diseases in nerve circulatory system, especially for heart failure and hypertension. CONSTITUTI...
|
|
JPH0518840B2 |
This invention relates to hydroxylated derivatives of vitamin D2, to processes for preparing such compounds, to intermediates utilized in such processes and to certain isotopically labelled vitamin D2 compounds. The vitamin D2 derivative...
|
|
JPH0518839B2 |
This invention relates to hydroxylated derivatives of vitamin D2, to processes for preparing such compounds, to intermediates utilized in such processes and to certain isotopically labelled vitamin D2 compounds. The vitamin D2 derivative...
|
|
JPH0515720B2 |
14,17 beta -ethano-14 beta -estratriene and estratetraene of Formula I (I) wherein R1 is a hydrogen atom, a methyl or an acyl group of a monocarboxyclic acid of 1-12 carbon atoms, R2 is a hydrogen atom or an acyl group of a monocarboxyli...
|
|
JPH054397B2 |
Novel 3-keto-19-nor- DELTA 4,9-steroids of the formula I
|
|
JPH053852B2 |
|
